AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank33
3Y CAGR-15.5%
5Y CAGR+71.0%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-15.5%/yr
Annual compound
5Y CAGR
+71.0%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
14.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $61.95M | -32.7% |
| 2024 | $92.09M | -33.6% |
| 2023 | $138.74M | +35.3% |
| 2022 | $102.56M | +57.0% |
| 2021 | $65.32M | +1442.7% |
| 2020 | $4.23M | -25.7% |
| 2019 | $5.70M | - |